Literature DB >> 1961254

Cholinergic modulation of [3H]dopamine release from dendrosomes of rat substantia nigra.

M Marchi1, A Augliera, A Codignola, G Lunardi, E Fedele, G Fontana, M Raiteri.   

Abstract

Dendrosomes prepared from substantia nigra are able to take up and release [3H]dopamine in a CA(2+)-dependent manner. The Vmax values of [3H]dopamine uptake in substantia nigra dendrosomes was about 5 times lower than that in caudate putamen synaptosomes. The pattern of the K(+)-dependency of the [3H]dopamine release in substantia nigra dendrosomes was significantly different from that found in caudate putamen synaptosomes. The release of [3H]dopamine evoked by 15 mmol/l KCl from superfused dendrosomes was increased in a concentration-dependent manner by acetylcholine. The maximal potentiation produced by acetylcholine was about 40%. The potentiation of [3H]dopamine release by 10 mumol/l acetylcholine was insensitive to mecamylamine but antagonized by atropine and by pirenzepine. The effects of acetylcholine on the release of [3H]acetylcholine from substantia nigra nerve endings was also studied. Exogenous acetylcholine added to the superfusion medium decreased in a concentration-dependent manner the release of acetylcholine. This effect was not antagonized by mecamylamine or pirenzepine but fully antagonized by atropine. The data suggest the existence, in the substantia nigra of the rat, of two distinct muscarinic receptor subtypes regulating respectively dopamine release from dopamine dendrites and acetylcholine release from cholinergic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961254     DOI: 10.1007/bf00183000

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  39 in total

1.  Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals.

Authors:  A Björklund; O Lindvall
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

Review 2.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

3.  Release of dopamine in vivo from cat substantia nigra.

Authors:  A Nieoullon; A Cheramy; J Glowinski
Journal:  Nature       Date:  1977-03-24       Impact factor: 49.962

4.  A simple apparatus for studying the release of neurotransmitters from synaptosomes.

Authors:  M Raiteri; F Angelini; G Levi
Journal:  Eur J Pharmacol       Date:  1974-03       Impact factor: 4.432

5.  The localization of receptor binding sites in the substantia nigra and striatum of the rat.

Authors:  T D Reisine; J I Nagy; K Beaumont; H C Fibiger; H I Yamamura
Journal:  Brain Res       Date:  1979-11-16       Impact factor: 3.252

6.  Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.

Authors:  M Raiteri; R Leardi; M Marchi
Journal:  J Pharmacol Exp Ther       Date:  1984-01       Impact factor: 4.030

7.  Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine.

Authors:  J Lehmann; S Z Langer
Journal:  Brain Res       Date:  1982-09-23       Impact factor: 3.252

8.  Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.

Authors:  E Kelly; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1985-07       Impact factor: 5.372

9.  [3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions.

Authors:  A J Cross; J L Waddington
Journal:  Neurosci Lett       Date:  1980-05-01       Impact factor: 3.046

10.  Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

Authors:  M F Giorguieff; M L Le Floc'h; J Glowinski; M J Besson
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.